This community is part of Research Directions - a journal collection based around cutting edge research questions.

Neuroimmune-Mediated Mood/Psychotic Syndromes: A case Series (n=45) Treated with Immunotherapy

07 November 2024, Version 1
This content is an early or alternative research output and has not been peer-reviewed by Cambridge University Press at the time of posting.
This item is a response to a research question in Depression
Q. Is immune activation simply a non-specific marker of depression severity or chronicity or does it indicate an underlying pathophysiological path to depressive or other mood disorders?

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting and Discussion Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.